Neutrophil-to-Lymphocyte Ratio and All-Cause and Heart Disease Mortality in Adults with Obstructive Sleep Apnea-Related Symptoms: A Population-Based Study
Obstructive sleep apnea (OSA) is associated with increased mortality risk, but the prognostic relevance of routinely available inflammatory biomarkers in adults with OSA-related symptoms remains incompletely characterized. This study aimed to compare hematological inflammatory indices in relation to all-cause and heart disease mortality among adults with OSA-related symptoms. Using National Health and Nutrition Examination Survey (NHANES) data from 2005–2008 and 2015–2018, we evaluated six inflammatory indices in relation to mortality using survey-weighted Cox regression, restricted cubic spline analyses, and time-dependent discrimination assessments. Primary association analyses modeled inflammatory indices continuously with effect estimates expressed per one standard deviation (SD) increase. The data-derived NLR (neutrophil-to-lymphocyte ratio) cutoff of 3.3 was examined exploratorily, with bootstrap resampling used to assess cutoff-selection stability. Among 4,559 adults with OSA-related symptoms, 452 deaths occurred, including 94 from heart disease. Each 1-SD increase in NLR was associated with higher all-cause mortality (adjusted Hazard Ratio (HR), 1.145; 95% Confidence Interval (CI), 1.050–1.248; p = 0.002). At 5 years, NLR showed greater discrimination than PIV (pan-immune-inflammation value) (ΔArea under the Curve (AUC), 0.064; p = 0.007), whereas its difference from SII (systemic immune inflammation index) was not statistically significant (ΔAUC, 0.034; p = 0.238). Adding NLR to the clinical model yielded limited incremental discrimination (ΔC-index, 0.002; p = 0.060). In an exploratory analysis, NLR ≥ 3.3 was associated with higher all-cause mortality (adjusted HR, 1.80; 95% CI, 1.34–2.41). The association between elevated NLR and heart disease mortality varied over follow-up (p for proportional hazards assumption
Authors
- Tian Lv (ORCID: https://orcid.org/0000-0002-9580-9990)
- Yu Pei Xiao (ORCID: https://orcid.org/0000-0001-5668-7241)
- Junjian Dai (ORCID: https://orcid.org/0000-0001-8857-5746)
- Chenxi Wang
- Shiping Sun (ORCID: https://orcid.org/0009-0007-5121-231X)
- Fuke Wang (ORCID: https://orcid.org/0000-0002-0134-7095)
Institutions
- Shanghai Jiao Tong University (CN)
- Fudan University (CN)
- Kunming Medical University (CN)
- Wenzhou Medical University (CN)
- Peking University Cancer Hospital (CN)
- Suzhou Municipal Hospital (CN)
- First Affiliated Hospital of Kunming Medical University (CN)
- Zhongshan Hospital (CN)
- Shanghai Sixth People's Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- ENT Updates
- Published
- 2026-11-16
- DOI
- https://doi.org/10.54963/entu.v16i4.106179
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00